Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

SABCS 2023: Potentially targetable fusion RNAs may be more common in metastatic breast cancer than previously realised

SABCS 2023: Potentially targetable fusion RNAs may be more common in metastatic breast cancer than previously...

SABCS 2023: Some breast cancer survivors may safely de-escalate mammography three years after surgery

SABCS 2023: Some breast cancer survivors may safely de-escalate mammography three years after surgery

ESMO 2023: Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

ESMO 2023: Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or...

A novel targeted molecular therapy for drug-resistant biliary tract cancer

A novel targeted molecular therapy for drug-resistant biliary tract cancer

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain barrier and exhibits potent activity against glioblastoma

Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain...

Survival of the fittest? New study shows how cancer cells use cell competition to evade the body’s defenses

Survival of the fittest? New study shows how cancer cells use cell competition to evade the body’s defenses

FDA approves nirogacestat for desmoid tumours

FDA approves nirogacestat for desmoid tumours

Robust chromatin map explains heterogeneity of paediatric acute lymphoblastic leukaemia

Robust chromatin map explains heterogeneity of paediatric acute lymphoblastic leukaemia

FDA approves capivasertib with fulvestrant for breast cancer

FDA approves capivasertib with fulvestrant for breast cancer

More from ecancer